Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke
- PMID: 28389610
- DOI: 10.1161/STROKEAHA.116.016071
Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke
Abstract
Background and purpose: Hyperglycemia on admission is common after ischemic stroke. It is associated with unfavorable outcome after treatment with intravenous thrombolysis and after intra-arterial treatment. Whether hyperglycemia influences the effect of reperfusion treatment is unknown. We assessed whether increased admission serum glucose modifies the effect of intra-arterial treatment in patients with acute ischemic stroke.
Methods: We used data from the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Hyperglycemia was defined as admission serum glucose >7.8 mmol/L. The primary outcome measure was the adjusted common odds ratio for a shift in the direction of a better outcome on the modified Rankin Scale at 90 days, estimated with ordinal logistic regression. Secondary outcome variable was symptomatic intracranial hemorrhage. We assessed treatment effect modification of hyperglycemia and admission serum glucose levels with multiplicative interaction factors and adjusted for prognostic variables.
Results: Four hundred eighty-seven patients were included. Mean admission serum glucose was 7.2 mmol/L (SD, 2.2). Fifty-seven of 226 patients (25%) randomized to intra-arterial treatment were hyperglycemic compared with 61 of 261 patients (23%) in the control group. The interaction of either hyperglycemia or admission serum glucose levels and treatment effect on modified Rankin Scale scores was not significant (P=0.67 and P=0.87, respectively). The same applied for occurrence of symptomatic hemorrhage (P=0.39 for hyperglycemia, P=0.39 for admission serum glucose).
Conclusions: We found no evidence for effect modification of intra-arterial treatment by admission serum glucose in patients with acute ischemic stroke.
Clinical trial registration: URL: www.isrctn.com. Unique identifier: ISRCTN10888758.
Keywords: glucose; hemorrhages; hyperglycemia; stroke; thrombectomy.
© 2017 American Heart Association, Inc.
Similar articles
-
Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands).Stroke. 2017 Jul;48(7):1869-1876. doi: 10.1161/STROKEAHA.116.016225. Epub 2017 Apr 21. Stroke. 2017. PMID: 28432266 Clinical Trial.
-
Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke.Stroke. 2016 Dec;47(12):2972-2978. doi: 10.1161/STROKEAHA.116.014565. Epub 2016 Nov 8. Stroke. 2016. PMID: 27827328 Clinical Trial.
-
Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort.J Neurol Sci. 2016 Dec 15;371:1-5. doi: 10.1016/j.jns.2016.10.003. Epub 2016 Oct 6. J Neurol Sci. 2016. PMID: 27871427 Clinical Trial.
-
Endovascular Treatment of Ischemic Stroke: An Updated Meta-Analysis of Efficacy and Safety.Vasc Endovascular Surg. 2017 May;51(4):215-219. doi: 10.1177/1538574417698905. Epub 2017 Mar 17. Vasc Endovascular Surg. 2017. PMID: 28424039 Review.
-
Intra-arterial thrombolysis and thrombectomy for acute ischemic stroke: technique and results.J Neurosurg Sci. 2011 Jun;55(2):151-60. J Neurosurg Sci. 2011. PMID: 21623327 Review.
Cited by
-
A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy.Front Neurol. 2023 Mar 21;14:1149671. doi: 10.3389/fneur.2023.1149671. eCollection 2023. Front Neurol. 2023. PMID: 37025208 Free PMC article. Review.
-
Clinical relevance of glucose metrics during the early brain injury period after aneurysmal subarachnoid hemorrhage: An opportunity for continuous glucose monitoring.Front Neurol. 2022 Sep 12;13:977307. doi: 10.3389/fneur.2022.977307. eCollection 2022. Front Neurol. 2022. PMID: 36172028 Free PMC article. Review.
-
Inhibition of HDAC3 Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice In Vivo and In Vitro.J Diabetes Res. 2019 Feb 13;2019:8520856. doi: 10.1155/2019/8520856. eCollection 2019. J Diabetes Res. 2019. PMID: 30906786 Free PMC article.
-
Association Between Admission Hyperglycemia and Outcomes After Endovascular Treatment in Acute Basilar Artery Occlusion.Neurol Ther. 2023 Aug;12(4):1285-1297. doi: 10.1007/s40120-023-00502-8. Epub 2023 Jun 2. Neurol Ther. 2023. PMID: 37266794 Free PMC article.
-
Elevated Glycated Hemoglobin Levels Are Associated With Poor Outcome in Acute Ischemic Stroke.Front Aging Neurosci. 2022 Feb 3;13:821336. doi: 10.3389/fnagi.2021.821336. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35185521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical